AKT1 and Hashimoto thyroiditis: Previous study revealed that tryptophan metabolism abnormality was related to Hashimoto's thyroiditis, and tryptophan could alleviate the disease by regulating T cell function and the PI3K‐Akt pathway, which suggested tryptophan metabolism might be a potential therapeutic target for Hashimoto's thyroiditis (Zhang et al. 2025).